Characterization of Anti-HIV Antibodies
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Inserm
Other organizations : Sorbonne Paris Cité, Université Paris Cité, Department of Virology, Université de Tours, Central European Institute of Technology, Central European Institute of Technology – Masaryk University, University of Amsterdam, Cornell University, Amsterdam University Medical Centers, Ragon Institute of MGH, MIT and Harvard, Harvard University, Massachusetts General Hospital, Rockefeller University, Centre de Recherche des Cordeliers, Sorbonne Université, Beth Israel Deaconess Medical Center, Institut de Chimie des Substances Naturelles, Université Paris-Saclay
Variable analysis
- Anti-V3^crown 10-188
- BNAbs 2G12
- Anti-CD4bs 3BNC117
- Anti-V3-glycan PGT121, PGT135, 10-1074, and BG8/BG18
- Anti-silent face SF12
- Polyreactive and nonpolyreactive antibody ED38
- MGO53
- 10-1074 and mGO53 IgA monoclonal antibodies
- Not explicitly mentioned
- Recombinant IgG and IgA antibodies were produced by cotransfection of Freestyle 293-F cells (Thermo Fisher Scientific) using PEI precipitation method as previously described (Lorin and Mouquet, 2015; Tiller et al., 2008) and purified by affinity chromatography using protein G Sepharose 4 fast flow beads (GE Healthcare) and peptide M-coupled agarose beads (InvivoGen), respectively.
- For competition ELISA experiments, purified antibodies were biotinylated using the EZ-Link Sulfo-NHS-Biotin kit (Thermo Fisher Scientific).
- Positive controls: None specified
- Negative controls: None specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!